Cantharide Patents (Class 424/541)
  • Patent number: 10172904
    Abstract: A formulation comprising a variety of Chinese herbs is disclosed for the treatment of cancer and side effects associated with the treatment of cancer.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: January 8, 2019
    Assignee: LIFEBIOTIC MEDICAL RESEARCH LTD
    Inventor: Yair N. Maimon
  • Patent number: 9023401
    Abstract: A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: May 5, 2015
    Assignee: Purdue Pharma L.P.
    Inventors: Benjamin Oshlack, Hua-Pin Huang, John K. Masselink, Alfred Tonelli
  • Patent number: 8927028
    Abstract: A dosage form exhibiting delayed transit time through the GI tract. The dosage form comprises a plurality of buoyant particles, each comprising an inner drug-containing core, an intermediate layer surrounding said core and a release rate-controlling outer coating.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: January 6, 2015
    Assignee: Jagotec AG
    Inventors: Pascal Grenier, Julien Taillemite, Severine Serreau, Alain Nhamias
  • Patent number: 8367119
    Abstract: The invention relates to the pharmaceutical composition for the treatment of a brain tumor, which contains in an effective amount from pharmaceutical point of view Peptidtoxin from spiders, Sicarius species and/or the saliva of the vipers from the Elaphe species; and the total poison or part of the spiders poison from the Latrodectus species, as well as the use of the pharmaceutical composition for the treatment of the brain tumor, a process for producing the pharmaceutical composition as well as a kit of parts containing the pharmaceutical composition.
    Type: Grant
    Filed: December 20, 2007
    Date of Patent: February 5, 2013
    Assignee: ABiTec Angewandte Bio-Technologie GbR
    Inventor: Dirk Weickmann
  • Publication number: 20110206774
    Abstract: A unique, synergistic formulation for the treatment of first-degree skin burns is provided for topical use and alleviates the full spectrum of symptoms and concerns associated with epidermal burns, including pain, blistering, redness, swelling, compromised skin integrity, risk of infection and scarring. The formulation contains natural homeopathic extracts combined with a pharmaceutically acceptable carrier suitable for topical administration. The formulation may include three or more of the following homeopathic extracts: Cantharis Vesicatoria, Echinacea Angustifolia, Calendula Officinalis and Hypericum Perforatum.
    Type: Application
    Filed: May 2, 2011
    Publication date: August 25, 2011
    Applicant: THE AKSHAY WELLNESS GROUP, INC.
    Inventor: Sai S. Manickam
  • Publication number: 20110135748
    Abstract: The present invention discloses use of a traditional Chinese medicinal composition for preparing medicine for promoting bond marrow-derived mesenchymal stem cell survival in vivo and differentiation into cardiomyocytes. The invention also relates to use of the traditional Chinese medicinal composition for preparing the medicines for treatment of cardiovascular disease in combination with autologous bone marrow-derived mesenchymal stem cells.
    Type: Application
    Filed: July 29, 2008
    Publication date: June 9, 2011
    Applicant: HEBEI YILING MEDICINE RESEARCH INSTITUTE CO., LTD.
    Inventors: Yuejin Yang, Haiyan Qian
  • Publication number: 20080206354
    Abstract: Disclosed herein is a hair growth-stimulating composition containing a non-polar solvent-soluble extract fraction of Cantharis as an active ingredient. The composition shows an excellent hair growth activity with minimal skin irritation compared to conventional ones. It can be used for hair growth in various fields, including medical and non-medical supplies and cosmetics.
    Type: Application
    Filed: January 18, 2006
    Publication date: August 28, 2008
    Applicant: Kwang Dong Pharm Co., Ltd.
    Inventors: Sang-Cheol Chi, Sung-Yong Kim
  • Publication number: 20040219226
    Abstract: A complex prescription of Chinese medicine for the treatment of extensive cancer, or cancer of relation type of the lymph node. The ingredients of this complex prescription are Pilose asiabell root, Astragalus root, Coix seed, Eupatorium, Tangerine peel, Justicia, Prunella spike, Serissa serissoides, Capejasmine fruit, Forsythia fruit, Red peony root, Rhubarb, Blister beetle, Oldenlandia, Polygonum perfoliatum, Subprostrate sophora root, Shrubalthea bark, Rhizome of arisaema, Chinese Lobelia, Ampelopsis, Globethistle, Pyrrosia leaf, Frankincense, Myrrh, Paris chinensis franch, Patrinia, Dahurian angelica root, Belamcanda rhizome, Dandelion herb, Lemmaphyllum microphyllum, Gleditsia spine, Pubescent angelica root, Chinese Ephedra, and Cimicifuga rhizome. The extraction is improved and it also adopts Indian Bread (Poria), an effective cancer medicine, as excipient.
    Type: Application
    Filed: June 10, 2003
    Publication date: November 4, 2004
    Inventor: Chien-Yung Lee
  • Patent number: 5747005
    Abstract: The present invention provides an oil-based, anti-plaque dentifrice comprising vitamin E and an enzyme in an admixture which is effective to dissolve plaque and to resist plaque formation. The preferred dentifrice composition is substantially anhydrous, and includes a chelating agent and a promoter to assist the enzyme in fighting plaque.
    Type: Grant
    Filed: August 2, 1995
    Date of Patent: May 5, 1998
    Inventors: Ronald R. Barels, Charles M. Cohler